It's Your Health
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
Every year, Health Canada receives hundreds of new clinical trial applications for testing new drugs or new uses of approved drugs on humans. These trials give Canadians a chance to take part in research that could improve their health. Clinical trials can be an important treatment option, but like all drugs, the ones used in clinical trials have potential benefits as well as risks because there is usually limited information about the safety and efficacy of the drug being studied.
Before you take part in a clinical trial, you should discuss the potential risks and benefits with your health care provider, so that you can make an informed decision about your health and participation in a study.
When researchers develop new drugs, the first tests are called pre-clinical studies. These tests are done using cells, tissue samples, or animals. If the results are promising, the next step is a clinical trial.
Clinical trials are studies to find out whether the drug is safe and effective for people. The people who take part in trials are volunteers. They may be patients with a specific disease, or healthy people wanting to contribute to the advancement of medical knowledge.
The individual or organization that wants to test the drug is called the sponsor. Health Canada does not sponsor or conduct drug research. Clinical trial sponsors are usually drug companies, or researchers from a hospital, university, or research organization.
Before conducting a trial, the sponsor submits a clinical trial application to Health Canada. Our scientists review the application to make sure:
Clinical trials in Canada are done under strict conditions defined in Canadian Regulations and must follow Good Clinical Practices. The regulatory framework was put in place to:
The people who carry out clinical trials are called investigators. Canadian law requires that investigators are physicians or dentists. Other staff that could be involved in a clinical trial includes researchers, nurses, or other health professionals. Most often, the trials have research teams and take place in hospitals, medical clinics, doctors' offices, and universities.
Clinical trials are done in phases. Each phase has a different purpose and helps researchers answer specific questions.
When you take part in a clinical trial, you help others by advancing medical research. If you have a disease, there could be personal benefits.
If your reason for being in a clinical trial is to get access to a new treatment, be aware that this may not happen. Clinical trials often compare a new drug to:
In many cases, people are not told which treatment they are getting in order to generate unbiased results. Even if you get the new drug, it may not help you. It might be less effective than a treatment you were using before the trial. There is also a risk of serious side effects (short-term and long-term) as the safety profile of an investigational drug is not as well understood as an approved drug
A clinical trial can take up a lot of your time for things like travel, tests and even hospital stays.
Every person who participates in a clinical trial must give their informed consent before beginning in the trial. Study the Informed Consent form before you decide whether to join a clinical trial. It tells you the benefits and risks so you can make an informed decision about your health and your decision to participate. Discuss it with your family and friends. If you have concerns, talk them over with your health professional.
If you decide to join a clinical trial:
You have the right to quit a clinical trial at any time. If you quit, the trial's medical staff will make sure you are taken off the medication safely.
The diagram below shows how clinical trials fit into Canada's system for drug approvals.
Figure 1: Regulatory process for drugs in Canada
The exhibit shows the steps in the regulatory process for drugs in Canada, from pre-market to post-market. The pre-market part of the process starts with pre-clinical studies. The steps are :
If clinical trials prove that a drug's benefits outweigh the risks, and the company that makes the drug wants to market that drug in Canada, it applies to Health Canada for market approval. This involves submitting detailed information about the drug's safety, effectiveness and quality, like:
Health Canada's scientists review this information. If they conclude that the benefits outweigh the risks, and that risks are being kept as low as possible, the drug is approved for sale in Canada. The new drug then gets:
Health Canada plays an active role in making sure Canadians have access to safe and effective drugs. As part of this work, we protect the health of Canadians who take part in clinical trials. For example, we:
If there are severe side effects, we may stop the trial or require that patients be monitored more closely.
We also give Canadians information about clinical trials so that they can make informed decisions about their health. Our website lists all the phase I, II, and III drug patient clinical trials in Canada. The list is updated each night, and has information like:
In addition, the Canadian Institutes of Health Research provides funds to support all areas of health research, including clinical trials.
You can also call toll free at 1-866-225-0709 or TTY at 1-800-465-7735*
Original: May 2013
ęHer Majesty the Queen in Right of Canada, represented by the Minister of Health, 2013
Catalogue # H13-7/130-2013E-PDF
ISBN # 978-1-100-22331-5